Status:
COMPLETED
Fear Potentiation and Fear Inhibition in Posttraumatic Stress Disorder
Lead Sponsor:
Emory University
Conditions:
Posttraumatic Stress Disorder
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The current study will investigate the ability of people with and without fear symptoms after trauma to inhibit fear in an experimental situation.
Detailed Description
Title of addendum: fear potentiation, conditional discrimination, and fear inhibition in posttraumatic stress disorder. Principal Investigator: Erica Duncan, M.D. Co-Investigator: Seth Norrholm, M.D...
Eligibility Criteria
Inclusion
- Age 18-80
- Diagnosis of PTSD
- Healthy controls (no history of PTSD)
- Combat controls (no history of PTSD)
Exclusion
- No drug or alcohol abuse or dependence
Key Trial Info
Start Date :
January 1 2001
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 22 2012
Estimated Enrollment :
425 Patients enrolled
Trial Details
Trial ID
NCT00209040
Start Date
January 1 2001
End Date
February 22 2012
Last Update
August 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Atlanta VA Medical Center
Decatur, Georgia, United States, 30033